Genprex, Inc.
NASDAQ: GNPX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ryan Confer
- Employees
- 15
- Headquarters
- Austin, United States
- IPO year
- 2018
- Market cap
- $788.2K
- Website
- https://www.genprex.com
Loading GNPX…
Loading profile data…Frequently asked questions about GNPX
What does Genprex, Inc. (GNPX) do?
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically de...
Where does GNPX trade?
Genprex, Inc. (GNPX) trades on the NASDAQ Capital Market.
What sector is GNPX in?
Genprex, Inc. (GNPX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genprex, Inc.?
Ryan Confer is the chief executive officer of Genprex, Inc. (GNPX).
Where is Genprex, Inc. headquartered?
Genprex, Inc. is headquartered in United States.
Does GNPX pay a dividend?
Genprex, Inc. (GNPX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNPX go public?
Genprex, Inc. (GNPX) completed its initial public offering in 2018.